Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by biodelatechon Jul 21, 2008 4:54pm
468 Views
Post# 15314289

Free at last

Free at lastI think  my post  must have hurt/pissed offRoche so much that they threw in the towel soon afterwards.
But seriously, we are in a better situation right now.
One drug with many indications with at least two partners for different  major indications would never have worked.
Just imagine pricing: one partner could have undercut the other or the cheaper voclo could have gone `off-label´against the dearer one. you don´t need an MBA to understand that this can´t work.
Now Voclosporin has been freed from the hostage takers. No matter that we kind of offered them voclo as a hostage.
Voclo is free now.
We can offer it to ONE partner for nearly  ALL  indications worldwide.  And it´s not going to be Roche. You can´t ask for much more.
My guesstimate: we´ll close above 50 cents tomorrow and soon Novartis or Astellas will be announced as a partner.





Bullboard Posts